Latest Headlines
-
INL's Nanosafety Laboratory Achieves OECD Good Laboratory Practice Certification
10/3/2024
The International Iberian Nanotechnology Laboratory (INL) proudly announces that its Nanosafety Laboratory has been officially recognised by the Portuguese Institute for Quality (IPQ) for meeting the stringent compliance requirements of the Organisation for Economic Co-operation and Development (OECD) Principles of Good Laboratory Practices (GLP).
-
RXNT Acquires Scalabull, Streamlining Clinical Lab And Facility Interfacing For Providers Nationwide
10/2/2024
RXNT, a Maryland-based healthcare technology leader, has acquired Scalabull, a nationwide interfacing network that empowers EHR systems to connect with clinical laboratories and radiology facilities, continuing the shift toward accelerated, sustainable growth in 2024.
-
Thermo Fisher Scientific Introduces Mass Spectrometers To Simplify Trace Elemental Analysis And Enhance Productivity
10/1/2024
Thermo Fisher Scientific Inc. today launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS).
-
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing From Centers For Medicare And Medicaid Services (CMS) For AI-Powered Cardiovascular Tests
10/1/2024
Cardio Diagnostics Holdings, Inc., an AI-driven precision cardiovascular medicine company today announced that the Company’s PrecisionCHD and Epi+Gen CHD tests have received preliminary pricing determinations from the Centers for Medicare & Medicaid Services (CMS).
-
PacBio, A*STAR, And Macrogen Unveil State-Of-The-Art Lab To Accelerate Genomics Innovation In Singapore
10/1/2024
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the Agency for Science, Technology, and Research (A*STAR), and Macrogen, today announced the opening of a state-of-the-art joint laboratory at A*STAR Genome Institute of Singapore (A*STAR GIS) in Singapore.
-
Geneoscopy Receives New York State Department Of Health Permit, Expanding Ability To Provide Laboratory Services Nationwide
10/1/2024
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, received its laboratory permit from the New York State Department of Health.
-
Scilutions Unveils Pulp Fixin, The First Ever Biodegradable Automation Rack For Clinical Laboratories
9/30/2024
Scientific instrument manufacturer Scilutions has released 100% biodegradable and recyclable automation racks made from paper pulp.
-
QIAGEN Launches QIAcuityDx Digital PCR System For Clinical Testing In Oncology
9/30/2024
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its digital PCR portfolio now expanding into clinical diagnostics.
-
Accelerate Diagnostics Announces FDA Clearance Of Its Accelerate Arcâ„¢ System
9/30/2024
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the Accelerate Arc system and BC kit, an innovative, automated positive blood culture sample preparation platform, for use with Bruker's MALDI Biotyper® CA System (MBT-CA System) and MBT-CA Sepsityper® software extension.
-
Quanterix Announces Commercialization Of p-Tau 217 Test Kit
9/30/2024
Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced it is making its Simoa® p-Tau 217 Planar Kit commercially available as part of the next phase of Alzheimer’s Disease (AD) test development.